FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.7050
-0.1250 (-15.06%)
At close: Nov 20, 2026, 4:00 PM EST
0.7220
+0.0170 (2.41%)
After-hours: Nov 20, 2026, 7:45 PM EST
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year. That makes FibroBiologics the 39,187th largest employer in the world and 5,696th in the United States.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,093,933
Market Cap
4.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Longeveron | 38 |
| SeaStar Medical Holding | 18 |
| Soligenix | 14 |
| Processa Pharmaceuticals | 12 |
| AEON Biopharma | 8 |
| Enveric Biosciences | 6 |
| Cadrenal Therapeutics | 5 |
FBLG News
- 1 day ago - FibroBiologics price target lowered to $4 from $6 at H.C. Wainwright - TheFly
- 4 days ago - FibroBiologics Reports Third Quarter 2026 Financial Results; Highlights Upcoming Catalysts - PRNewsWire
- 5 days ago - FibroBiologics Quarterly report: Q3 2026 - Filings
- 5 days ago - FibroBiologics Earnings release: Q3 2026 - Filings
- 9 days ago - FibroBiologics provides update on IP portfolio - TheFly
- 9 days ago - FibroBiologics Announces Update On Its Intellectual Property Portfolio - PRNewsWire
- 16 days ago - FibroBiologics granted European Patent No. EP 4454709 - TheFly
- 16 days ago - FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents - PRNewsWire